Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Pain 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Uterine Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Mouth Neoplasms 1 Lung Neoplasms 1 Leiomyoma 1 Inflammation 1 Hyperuricemia 1 Gout 1 Dysmenorrhea 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Arthritis 1

Interventions

telapristone acetate 18 ulipristal acetate 17 Uterine Myomectomy 13 vilaprisan 12 Leuprolide 11 relugolix 9 estradiol, norethindrone drug combination 9 asoprisnil 9 elagolix 7 Uterine Artery Embolization 7 Mifepristone 7 Estradiol 7 Bupivacaine 7 ulipristal 6 Tranexamic Acid 6 Saline Solution 5 Norethindrone Acetate 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Letrozole 4 Hysterectomy 4 Vitamin B 6 3 Sugars 3 Misoprostol 3 Lidocaine 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Leiomyoma × Naproxen × Clear all

NCT04145518 2025-12-12

MCUP

Endeavor Health

Phase 4 Completed

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡